Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001001593 | SCV001159006 | benign | Hemolytic anemia due to glutathione reductase deficiency | 2024-11-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001713060 | SCV001939193 | benign | not provided | 2021-06-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001713060 | SCV002433698 | benign | not provided | 2025-01-19 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001713060 | SCV005271810 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003973019 | SCV004788435 | benign | GSR-related disorder | 2019-03-28 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |